Kiladjian, Jean-jacques: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis

Silver, Richard T, Kiladjian, Jean-Jacques, Hasselbalch, Hans Carl

Journal:

Expert Review of Hematology

Year:

2013

Language:

english

File:

PDF, 942 KB

english, 2013

2

Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study

Harrison, Claire N, Schaap, Nicolaas, Vannucchi, Alessandro M, Kiladjian, Jean-Jacques, Tiu, Ramon V, Zachee, Pierre, Jourdan, Eric, Winton, Elliott, Silver, Richard T, Schouten, Harry C, Passamonti,

Journal:

The Lancet Haematology

Year:

2017

Language:

english

File:

PDF, 757 KB

english, 2017

3

Novel insights into the biology and treatment of chronic myeloproliferative neoplasms*

Mughal, Tariq I., Barbui, Tiziano, Abdel-Wahab, Omar, Kralovics, Robert, Jamieson, Catriona, Kvasnicka, Hans-Michael, Mullaly, Ann, Rampal, Raajit, Mesa, Ruben, Kiladjian, Jean-Jacques, Deininger, Mic

Journal:

Leukemia and Lymphoma

Year:

2014

Language:

english

File:

PDF, 1022 KB

english, 2014

4

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet

Barbui, Tiziano, Tefferi, Ayalew, Vannucchi, Alessandro M., Passamonti, Francesco, Silver, Richard T., Hoffman, Ronald, Verstovsek, Srdan, Mesa, Ruben, Kiladjian, Jean-Jacques, Hehlmann, Rȕdiger, Reit

Journal:

Year:

2018

Language:

english

File:

PDF, 586 KB

english, 2018

5

Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses

Verstovsek, Srdan, Gotlib, Jason, Mesa, Ruben A., Vannucchi, Alessandro M., Kiladjian, Jean-Jacques, Cervantes, Francisco, Harrison, Claire N., Paquette, Ronald, Sun, William, Naim, Ahmad, Langmuir, P

Journal:

Journal of Hematology & Oncology

Year:

2017

Language:

english

File:

PDF, 1.01 MB

english, 2017

6

Aplastic anaemia in a case of hereditary neutrophil Fcγ receptor IIIb deficiency

Olivier Tournilhac, Jean-Jacques Kiladjian, Jean-Michel Cayuela, Maria-Eléna Noguera, Jean-Marc Zini, Marie-Thérèse Daniel, Odile Maarek, ÉLiane Gluckman, Gérard Socié, François Sigaux

Journal:

British Journal of Haematology

Year:

1997

Language:

english

File:

PDF, 547 KB

english, 1997

7

Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients

Eirini Kouroupi, Katerina Zoi, Nathalie Parquet, Christine Zoi, Jean-Jacques Kiladjian, Vassiliki Grigoraki, William Vainchenker, Franck Lellouche, Christophe Marzac, Marie-Hélène Schlageter, Christin

Journal:

British Journal of Haematology

Year:

2008

Language:

english

File:

PDF, 71 KB

english, 2008

8

PEG-IFN-α-2a therapy in patients with myelofibrosis : A study of the French Groupe d’Etudes des Myelofibroses (GEM) and France Intergroupe des syndromes Myéloprolifératifs (FIM)

Jean-Christophe Ianotto, Jean-Jacques Kiladjian, Jean-Louis Demory, Lydia Roy, Françoise Boyer, Jerôme Rey, Brigitte Dupriez, Christian Berthou, Jean-François Abgrall

Journal:

British Journal of Haematology

Year:

2009

Language:

english

File:

PDF, 67 KB

english, 2009

9

Identification of JAK2 mutations in canine primary polycythemia

Stephanie Beurlet, Patricia Krief, Arnaud Sansonetti, Alexandra Briend-Marchal, Jean-Jacques Kiladjian, Rose Ann Padua, Christine Chomienne, Bruno Cassinat

Journal:

Experimental Hematology

Year:

2011

Language:

english

File:

PDF, 364 KB

english, 2011

10

4 Megakaryocytes and platelets in myeloproliferative disorders

Jean Briere, Jean-Jacques Kiladjian, Edith Peynaud-Debayle

Journal:

Baillière's Clinical Haematology

Year:

1997

Language:

english

File:

PDF, 1.71 MB

english, 1997

11

Is life expectancy of polycythemia vera patients clearly different from that of the general population?

Jean-Jacques Kiladjian, Jean-Francois Bernard, Pierre Fenaux

Journal:

The American Journal of Medicine

Year:

2005

Language:

english

File:

PDF, 57 KB

english, 2005

12

JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis

Harrison, Claire, Kiladjian, Jean-Jacques, Al-Ali, Haifa Kathrin, Gisslinger, Heinz, Waltzman, Roger, Stalbovskaya, Viktoriya, McQuitty, Mari, Hunter, Deborah S., Levy, Richard, Knoops, Laurent, Cerva

Journal:

Boston Medical and Surgical Journal

Year:

2012

Language:

english

File:

PDF, 641 KB

english, 2012

13

Efficacy and Safety of Cytoreductive Therapies in Patients with Essential Thrombocythaemia Aged >80

Jean-Jacques Kiladjian, Carlos Besses, Martin Griesshammer, Luigi Gugliotta, Claire Harrison, Ruth Coll, Jonathan Smith, Gunnar Birgegård

Journal:

Clinical Drug Investigation

Year:

2013

Language:

english

File:

PDF, 480 KB

english, 2013

14

Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin

Casadevall, Nicole, Nataf, Joelle, Viron, Béatrice, Kolta, Amir, Kiladjian, Jean-Jacques, Martin-Dupont, Philippe, Michaud, Patrick, Papo, Thomas, Ugo, Valérie, Teyssandier, Irène, Varet, Bruno, Mayeu

Journal:

Boston Medical and Surgical Journal

Year:

2002

Language:

english

File:

PDF, 158 KB

english, 2002

15

Prognostic impact of JAK2V617F mutation in myelodysplatic syndromes: A matched case control study

de Renzis, Benoit, Mansat-De Mas, Veronique, Wattel, Eric, Beyne-Rauzy, Odile, Knoops, Laurent, Cabrespine, Aurélie, Azgui, Zahia, Ades, Lionel, Kiladjian, Jean-Jacques, Fenaux, Pierre

Journal:

Leukemia Research Reports

Year:

2013

Language:

english

File:

PDF, 240 KB

english, 2013

16

Cytoreductive treatment patterns for essential thrombocythemia in Europe. Analysis of 3643 patients in the EXELS study

Besses, Carlos, Kiladjian, Jean-Jacques, Griesshammer, Martin, Gugliotta, Luigi, Harrison, Claire, Coll, Ruth, Smith, Jonathan, Abhyankar, Brihad, Birgegård, Gunnar

Journal:

Leukemia Research

Year:

2013

Language:

english

File:

PDF, 410 KB

english, 2013

17

Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy

Harrison, Claire N., Mesa, Ruben A., Kiladjian, Jean-Jacques, Al-Ali, Haifa-Kathrin, Gisslinger, Heinz, Knoops, Laurent, Squier, Margaret, Sirulnik, Andres, Mendelson, Estella, Zhou, Xiaolei, Copley-M

Journal:

British Journal of Haematology

Year:

2013

Language:

english

File:

PDF, 316 KB

english, 2013

18

TET2 gene sequencing may be helpful for myeloproliferative neoplasm diagnosis

Verger, Emmanuelle, Andreoli, Annalisa, Chomienne, Christine, Kiladjian, Jean-Jacques, Cassinat, Bruno

Journal:

British Journal of Haematology

Year:

2014

Language:

english

File:

PDF, 144 KB

english, 2014

19

Characterization of different regimens for initiating anagrelide in patients with essential thrombocythemia who are intolerant or refractory to their current cytoreductive therapy: results from the multicenter FOX study of 177 patients in France

Rey, Jérôme, Viallard, Jean-François, Keddad, Karim, Smith, Jonathan, Wilde, Paul, Kiladjian, Jean-Jacques

Journal:

European Journal of Haematology

Year:

2014

Language:

english

File:

PDF, 413 KB

english, 2014

20

Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies

Mughal, Tariq I., Girnius, Saulius, Rosen, Steven T., Kumar, Shaji, Wiestner, Adrian, Abdel-Wahab, Omar, Kiladjian, Jean-Jacques, Wilson, Wyndham H., Van Etten, Richard A.

Journal:

Leukemia and Lymphoma

Year:

2014

Language:

english

File:

PDF, 1.91 MB

english, 2014

21

Ruxolitinib for the treatment of patients with polycythemia vera

Kiladjian, Jean-Jacques, Winton, Elliott F, Talpaz, Moshe, Verstovsek, Srdan

Journal:

Expert Review of Hematology

Year:

2015

Language:

english

File:

PDF, 360 KB

english, 2015

22

Interferon Alfa Therapy in CALR -Mutated Essential Thrombocythemia

Cassinat, Bruno, Verger, Emmanuelle, Kiladjian, Jean-Jacques

Journal:

New England Journal of Medicine

Year:

2014

Language:

english

File:

PDF, 459 KB

english, 2014

23

Treatment Strategies in Essential Thrombocythemia a critical appraisal of various experiences in different centers

Barbui, Tiziano, Finazzi, Guido, Dupuy, Evelyne, Kiladjian, Jean-Jacques, Brière, Jean

Journal:

Leukemia and Lymphoma

Year:

1996

Language:

english

File:

PDF, 1.15 MB

english, 1996

24

Long-Term Incidence of Hematological Evolution in Three French Prospective Studies of Hydroxyurea and Pipobroman in Polycythemia Vera and Essential Thrombocythemia

Kiladjian, Jean-Jacques, Rain, Jean-Didier, Bernard, Jean-Francois, Briere, Jean, Chomienne, Christine, Fenaux, Pierre

Journal:

Seminars in Thrombosis and Hemostasis

Year:

2006

Language:

english

File:

PDF, 80 KB

english, 2006

25

Lu/BCAM-mediated cell adhesion as biological marker of JAK2V617F activity in erythrocytes of polycythemia vera patients

De Grandis, Maria, Cassinat, Bruno, Kiladjian, Jean-Jacques, Chomienne, Christine, El Nemer, Wassim

Journal:

American Journal of Hematology

Year:

2015

Language:

english

File:

PDF, 229 KB

english, 2015

26

Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders

LI, Yan, Hetet, Gilles, Kiladjian, Jean-Jacques, Gardin, Claude, Grandchamp, Bernard, Briere, Jean

Journal:

British Journal of Haematology

Year:

1996

Language:

english

File:

PDF, 411 KB

english, 1996

27

Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy

Mesa, Ruben, Verstovsek, Srdan, Kiladjian, Jean-Jacques, Griesshammer, Martin, Masszi, Tamas, Durrant, Simon, Passamonti, Francesco, Harrison, Claire N., Pane, Fabrizio, Zachee, Pierre, Zhen, Huiling,

Journal:

European Journal of Haematology

Year:

2016

Language:

english

File:

PDF, 575 KB

english, 2016

28

Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast-phase myeloproliferative neoplasms

Devillier, Raynier, Raffoux, Emmanuel, Rey, Jérôme, Lengline, Etienne, Ronchetti, Anne-Marie, Sebert, Marie, Boissel, Nicolas, Robin, Marie, Vey, Norbert, Kiladjian, Jean-Jacques, Dombret, Herve, Cluz

Journal:

British Journal of Haematology

Year:

2016

Language:

english

File:

PDF, 69 KB

english, 2016

29

Chemotherapy for post-myelofibrosis acute myeloid leukemia: eradication of the leukemic clone but not the MPN clone

Verger, Emmanuelle, Rattarittamrong, Ekarat, Letort, Gil, Raffoux, Emmanuel, Cassinat, Bruno, Kiladjian, Jean-Jacques

Journal:

Leukemia and Lymphoma

Year:

2016

Language:

english

File:

PDF, 670 KB

english, 2016

30

Social Media and Myeloproliferative Neoplasms (MPN): Analysis of Advanced Metrics From the First Year of a New Twitter Community: #MPNSM

Pemmaraju, Naveen, Utengen, Audun, Gupta, Vikas, Kiladjian, Jean-Jacques, Mesa, Ruben, Thompson, Michael A.

Journal:

Current Hematologic Malignancy Reports

Year:

2016

Language:

english

File:

PDF, 3.56 MB

english, 2016

31

Place du ruxolitinib dans la stratégie thérapeutique des syndromes myéloprolifératifs

Soret, Juliette, Kiladjian, Jean-Jacques

Journal:

Bulletin du Cancer

Year:

2016

File:

PDF, 330 KB

2016

32

Brief report Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations

Passamonti, Francesco, Elena, Chiara, Schnittger, Susanne, Skoda, Radek C, Green, Anthony R, Kiladjian, Jean-jacques, Mcmullin, Mary Frances, Ruggeri, Marco, Besses, Carles, Vannucchi, Alessandro M, L

Year:

2015

Language:

english

File:

PDF, 120 KB

english, 2015

33

Markers of iron deficiency in patients with polycythemia vera receiving ruxolitinib or best available therapy

Verstovsek, Srdan, Harrison, Claire N., Kiladjian, Jean-Jacques, Miller, Carole, Naim, Ahmad B., Paranagama, Dilan C., Habr, Dany, Vannucchi, Alessandro M.

Journal:

Leukemia Research

Year:

2017

Language:

english

File:

PDF, 1.90 MB

english, 2017

34

Long-term treatment with interferon alfa for myeloproliferative neoplasms

Kiladjian, Jean-Jacques

Journal:

The Lancet Haematology

Year:

2017

Language:

english

File:

PDF, 124 KB

english, 2017

35

Enhanced calreticulin expression in red cells of polycythemia vera patients harboring the JAK2V617F mutation

Brusson, Mégane, Cochet, Sylvie, Leduc, Marjorie, Guillonneau, François, Mayeux, Patrick, Peyrard, Thierry, Chomienne, Christine, Le Van Kim, Caroline, Cassinat, Bruno, Kiladjian, Jean-Jacques, El Nem

Journal:

Year:

2017

Language:

english

File:

PDF, 1.26 MB

english, 2017

36

Ruxolitinib reducesJAK2p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study

Vannucchi, Alessandro Maria, Verstovsek, Srdan, Guglielmelli, Paola, Griesshammer, Martin, Burn, Timothy C., Naim, Ahmad, Paranagama, Dilan, Marker, Mahtab, Gadbaw, Brian, Kiladjian, Jean-Jacques

Journal:

Annals of Hematology

Year:

2017

Language:

english

File:

PDF, 629 KB

english, 2017

37

Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study

Poisson, Johanne, Plessier, Aurélie, Kiladjian, Jean-Jacques, Turon, Fanny, Cassinat, Bruno, Andreoli, Annalisa, De Raucourt, Emmanuelle, Goria, Odile, Zekrini, Kamal, Bureau, Christophe, Lorre, Flore

Journal:

Journal of Hepatology

Year:

2017

File:

PDF, 652 KB

2017

38

Actualités thérapeutiques dans les néoplasies myéloprolifératives non LMC

Roy, Lydia, Ugo, Valérie, Kiladjian, Jean-Jacques

Journal:

Revue Francophone des Laboratoires

Year:

2017

Language:

french

File:

PDF, 80 KB

french, 2017

39

European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia

Kvasnicka, Hans Michael, Orazi, Attilio, Thiele, Juergen, Barosi, Giovanni, Bueso-Ramos, Carlos E., Vannucchi, Alessandro M., Hasserjian, Robert P., Kiladjian, Jean-Jacques, Gianelli, Umberto, Silver,

Journal:

American Journal of Hematology

Year:

2017

Language:

english

File:

PDF, 983 KB

english, 2017

40

Treatment of essential thrombocythemia in Europe: a prospective long-term observational study of 3649 high-risk patients in the EXELS study

Birgegard, Gunnar, Besses, Carlos, Griesshammer, Martin, Gugliotta, Luigi, Harrison, Claire N., Hamdani, Mohamed, Wu, Jackie, Achenbach, Henri, Kiladjian, Jean-Jacques

Journal:

Year:

2017

Language:

english

File:

PDF, 966 KB

english, 2017

41

Rare Cancers and Social Media: Analysis of Twitter Metrics in the First 2 Years of a Rare-Disease Community for Myeloproliferative Neoplasms on Social Media—#MPNSM

Pemmaraju, Naveen, Utengen, Audun, Gupta, Vikas, Kiladjian, Jean-Jacques, Mesa, Ruben, Thompson, Michael A.

Journal:

Current Hematologic Malignancy Reports

Year:

2017

Language:

english

File:

PDF, 802 KB

english, 2017

42

Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studies

Kiladjian, Jean-Jacques, Guglielmelli, Paola, Griesshammer, Martin, Saydam, Guray, Masszi, Tamas, Durrant, Simon, Passamonti, Francesco, Jones, Mark, Zhen, Huiling, Li, Jingjin, Gadbaw, Brian, Perez R

Journal:

Annals of Hematology

Year:

2018

Language:

english

File:

PDF, 966 KB

english, 2018

43

Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project

Mora, Barbara, Giorgino, Toni, Guglielmelli, Paola, Rumi, Elisa, Maffioli, Margherita, Rambaldi, Alessandro, Caramella, Marianna, Komrokji, Rami, Gotlib, Jason, Kiladjian, Jean-Jacques, Cervantes, Fra

Journal:

Year:

2018

File:

PDF, 318 KB

2018

44

Next-generation sequencing for JAK2 mutation testing: advantages and pitfalls

Maslah, Nabih, Verger, Emmanuelle, Schlageter, Marie-Helene, Miclea, Jean-Michel, Kiladjian, Jean-Jacques, Giraudier, Stephane, Chomienne, Christine, Cassinat, Bruno

Journal:

Annals of Hematology

Year:

2018

Language:

english

File:

PDF, 612 KB

english, 2018

45

Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS study

Birgegård, Gunnar, Folkvaljon, Folke, Garmo, Hans, Holmberg, Lars, Besses, Carlos, Griesshammer, Martin, Gugliotta, Luigi, Wu, Jingyang, Achenbach, Heinrich, Kiladjian, Jean-Jacques, Harrison, Claire

Journal:

Leukemia Research

Year:

2018

Language:

english

File:

PDF, 229 KB

english, 2018

46

Thromboembolic events in polycythemia vera

Griesshammer, Martin, Kiladjian, Jean-Jacques, Besses, Carlos

Journal:

Annals of Hematology

Year:

2019

Language:

english

File:

PDF, 502 KB

english, 2019

47

SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis

Mesa, Ruben A., Kiladjian, Jean-Jacques, Catalano, John V., Devos, Timothy, Egyed, Miklos, Hellmann, Andrzei, McLornan, Donal, Shimoda, Kazuya, Winton, Elliott F., Deng, Wei, Dubowy, Ronald L., Maltzm

Journal:

Journal of Clinical Oncology

Year:

2017

File:

PDF, 861 KB

2017

48

How much does 2016 WHO classification of myeloproliferative neoplasms affect the clinic?

Cassinat, Bruno, Giraudier, Stephane, Kiladjian, Jean-Jacques

Journal:

Expert Review of Hematology

Year:

2019

Language:

english

File:

PDF, 634 KB

english, 2019

49

Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available

Foltz, Lynda, Pica, Gian-Matteo, Zerazhi, Hacene, Van Droogenbroeck, Jan, Visanica, Sorin, Báez de la Fuente, Enrique, Leber, Brian, de Almeida, Antonio Medina, Ranta, Dana, Kiladjian, Jean-Jacques, C

Journal:

Leukemia and Lymphoma

Year:

2019

Language:

english

File:

PDF, 1.23 MB

english, 2019

50

Ruxolitinib: a targeted treatment option for patients with polycythemia vera

Iesha, Lewis-Crofoot, Vaddi, Kris, Verstovsek, Srdan, Kiladjian, Jean-Jacques

Journal:

Blood and Lymphatic Cancer Targets and Therapy

Year:

2016

Language:

english

File:

PDF, 502 KB

english, 2016